Background: G6PD deficiency is the most common enzymopathy of red blood cells. The clinical symptoms of favism are jaundice, hematuria and haemolytic anaemia that seem to affect liver and kidney in long term. Thus we evaluate kidney and liver function of favism patients in an endemic area of the disease with a high rate of fava beans cultivation.

Methods: This study was performed on favism patients and healthy controls referring to Iranshahr central hospital. Liver and kidney function tests were performed.

Results: The results showed a statistically significant difference between these two groups (p <0.05) for liver function tests, (AST, ALT and ALP), but not for renal tests (BUN and creatinine) (p >0.05).

Conclusion: Due to abnormalities were seen in the liver function tests of these patients, we suggest that these tests be regularly performed for favism patients who are constantly exposed to oxidant agents.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592938PMC

Publication Analysis

Top Keywords

favism patients
16
liver kidney
12
kidney function
8
function favism
8
liver function
8
performed favism
8
function tests
8
favism
5
patients
5
evaluation liver
4

Similar Publications

Article Synopsis
  • - Glucose 6 phosphate dehydrogenase (G6PD) is a crucial enzyme in the pentose phosphate pathway, and its deficiency in red blood cells can lead to acute haemolytic anaemia, especially triggered by oxidative stress from infections or certain foods and medications, such as fava beans.
  • - A case study involving a 41-year-old woman from Italy revealed a novel genetic variant (c.1357G>A, p.(Val453Met)) linked to G6PD deficiency, confirmed through advanced DNA sequencing methods.
  • - The research emphasizes the significance of Sanger sequencing as a reliable method for confirming genetic variants, particularly for those that may be misidentified using initial testing methods, aligning with WHO guidelines
View Article and Find Full Text PDF
Article Synopsis
  • Direct-acting antivirals (DAAs) have made hepatitis C treatment much easier, but there’s limited info on how they work for patients with glucose-6-phosphate dehydrogenase deficiency (G6PDd).
  • A study looked at 2754 HCV-positive patients from 2015 to 2023, focusing on 38 with confirmed G6PDd, while monitoring their health closely during and after treatment.
  • Results showed no significant health issues or adverse events related to the treatment, with effectiveness similar to those without G6PDd, indicating that DAAs are safe for HCV treatment in these patients.
View Article and Find Full Text PDF

Consumption of fava beans in a patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency, also called favism, can lead to a haemolytic crisis. We report the case of a 69-year-old patient of Iranian origin admitted to the emergency department following syncope. The patient's comprehensive interview and blood analysis revealed that the patient presented a haemolytic crisis triggered by fava beans consumption, due to previously undiagnosed G6PD deficiency.

View Article and Find Full Text PDF

Correlating nanoscale motion and ATP production in healthy and favism erythrocytes: a real-time nanomotion sensor study.

Front Microbiol

June 2023

Biotech@ISM, Istituto di Struttura della Materia, Consiglio Nazionale delle Ricerche, Rome, Italy.

Introduction: Red blood cells (RBCs) are among the simplest, yet physiologically relevant biological specimens, due to their peculiarities, such as their lack of nucleus and simplified metabolism. Indeed, erythrocytes can be seen as biochemical machines, capable of performing a limited number of metabolic pathways. Along the aging path, the cells' characteristics change as they accumulate oxidative and non-oxidative damages, and their structural and functional properties degrade.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!